FDA sunscreen TFM proposed amendment on UVA testing methods, labeling upcoming.
This article was originally published in The Tan Sheet
Executive Summary
AVOBENZONE SUNSCREEN INTERIM MARKETING APPROVAL DUE BY END OF MARCH, FDA's John Lipnicki, an interdisciplinary scientist in the Division of OTC Drug Products, said at a sunscreen OTC "feedback" meeting with the Cosmetic, Toiletry & Fragrance Association and the Nonprescription Drug Manufacturers Association Feb. 11 in Rockville, Md. While "an estimate...on the completion time" for the final rule on OTC sunscreens is not available, FDA plans on "making a determination as soon as possible on the interim marketing status of avobenzone," Lipnicki said.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning